Search

A patent application titled "Feed Additive Composition" was published online, detailing a combination of direct-fed microbials (DFM) or probiotics with enzymes to improve nutrient utilization and production performance in animals. The application emphasizes the use of DFMs as antimicrobial replacements to reduce the need for antibiotics in animal feed, highlighting the potential benefits of inhibiting pathogen growth, stimulating immune function, and modulating microbial balance in the gastrointestinal tract. The composition includes specific bacterial strains like Bacillus subtilis and various proteases, aiming to enhance animal health and performance while reducing the reliance on antibiotics in the feed industry. [Extracted from the article]

Researchers from the Affiliated Jiangning Hospital of Nanjing Medical University in China have conducted a study on Chronic Obstructive Pulmonary Disease (COPD) and its association with oxidative stress. The study focused on the use of the probiotic Pediococcus pentosaceus SMM914 to delay COPD progression by reducing pulmonary oxidative stress. The research highlighted the importance of gut microbiota modulation and its impact on respiratory health through the gut-lung axis. The findings suggest that the probiotic intervention could potentially enhance gut probiotics abundance and the tryptophan-melatonin pathway to mitigate oxidative stress in COPD patients. [Extracted from the article]

Researchers from Dalian Polytechnic University in Liaoning, China, conducted a study on the use of probiotics, specifically Lactobacillus rhamnosus and Pediococcus acidilactici, to reduce the risk of atopic dermatitis (AD) in offspring mice by modulating the gut microbiota. The study found that supplementing pregnant mice with these probiotics led to mild AD symptoms in their offspring, attributed to changes in gut microbiota. The research suggests that these probiotics have the potential to reduce the risk of AD in offspring through the gut-mammary axis during pregnancy and lactation. [Extracted from the article]

A study conducted at Democritus University of Thrace investigated the effects of Pediococcus acidilactici ORE5 on the gut microbiome of diabetic rats when consumed with Corinthian currants. The research found that the group receiving immobilized P. acidilactici ORE5 showed lower levels of inflammatory cytokines and improved gut microbiome composition compared to the group receiving free cells. The study suggests that functional ingredients like Pediococcus acidilactici ORE5 could potentially help manage Type-1 Diabetes Mellitus-related gut dysbiosis, but further clinical trials are needed to confirm these effects. [Extracted from the article]

Researchers have submitted a patent application for a composition that includes probiotics engineered to express an enzyme involved in maintaining telomere length. Telomeres are protective caps at the ends of chromosomes that shorten with each cell division, impacting cellular aging. The composition aims to enhance telomerase activity safely and effectively, addressing challenges in current strategies for telomere maintenance. This innovative approach may offer a non-invasive and accessible method for promoting health and potentially extending lifespan. [Extracted from the article]

A study conducted at Sichuan University in Chengdu, People's Republic of China, explored the antimicrobial effects of two novel edible bacterial strains, Pediococcus pentosaceus and Lactococcus lactis, derived from the unique ecosystem of Bufo gargarizans. The research highlighted the significant antibacterial efficacy of these strains, their potential to mitigate pathogen-induced colitis, and improve gut microbiota. The study emphasized the strains' production of N-butyric acid, diverse biosynthetic pathways, and genes for bacteriocin production, suggesting their potential in combating antibiotic resistance and enhancing gastrointestinal health. [Extracted from the article]

The article discusses a clinical trial, NCT06648590, conducted by Wecare Probiotics Co., Ltd., to evaluate the effectiveness and safety of probiotics as food supplements compared to a placebo in improving digestive function and well-being in older adults aged 55-70. The trial involves 88 participants and aims to assess changes in gastrointestinal symptoms using the GSRS scale over a 56-day period. The study has specific eligibility criteria and exclusion criteria to ensure the safety and integrity of the research. [Extracted from the article]

A recent study conducted at Shihezi University in the People's Republic of China explored the proteomic profiling of Pediococcus pentosaceus SF11 exposed to condensed tannins from sainfoin. The research found that condensed tannins increased cell membrane permeability and inhibited cell reproduction in Pediococcus. The study identified differentially expressed proteins and concluded that the inhibition mechanism of condensed tannins may be related to cell membrane damage. For more information, the research article can be accessed through ACS Omega. [Extracted from the article]

Researchers from Prince of Songkla University in Thailand have conducted a study on Pediococcus pentosaceus, a strain of bacteria found in fermented foods. The study aimed to describe the genomic content of this strain and its potential probiotic abilities, including reducing cholesterol levels and producing g-aminobutyric acid (GABA). The researchers found that Pediococcus pentosaceus ENM104 has genes associated with probiotic traits, stress adaptation, bile tolerance, vitamin biosynthesis, immunomodulation, bacteriocin production, and lowering cholesterol levels. The strain also exhibited antibacterial activity against carbapenem-resistant bacteria. The study suggests that Pediococcus pentosaceus ENM104 has promising applications in the pharmaceutical and food industries, and further research is needed to explore its functional properties and efficacy in clinical settings. [Extracted from the article]

A recent study conducted by the National Institute for Communicable Disease Control and Prevention in Beijing, China, explored the effects of oral administration of Pediococcus pentosaceus MIANGUAN2 (MIANGUAN2) on influenza infection in mice. The results showed that MIANGUAN2 improved weight loss, lung index, lung pathology, and decreased lung viral load in the infected mice. Additionally, MIANGUAN2-treated mice exhibited lower levels of proinflammatory cytokines and higher production of anti-inflammatory cytokines in the lung. The study suggests that MIANGUAN2 may alleviate influenza infection by modulating the gut microbiota and enhancing the production of short-chain fatty acids. [Extracted from the article]

A recent study conducted by researchers at the Korea Food Research Institute in Wonju, South Korea, has found that the probiotic strain Pediococcus pentosaceus KF159 (PPKF159) may alleviate symptoms of atopic dermatitis (AD). The study used mouse models to evaluate the anti-allergic activity of PPKF159 and found that oral administration of the probiotic strain reduced clinical symptoms of AD, suppressed the production of Th2-associated cytokines and serum IgE, and increased T helper type 1 (Th1)-mediated cytokine production. PPKF159 also induced the transformation of dendritic cells into tolerogenic versions, which enhanced the production of IL10 and improved the secretion of CD4(+)CD25(+)Foxp3(+) Treg cells, ultimately improving AD. The researchers suggest that PPKF159 could be used as a functional food material for the treatment and prevention of AD. [Extracted from the article]

Researchers from Yan'an University in China have conducted a study on the impact of Pediococcus pentosaceus YF01 on the exercise capacity of mice. The study aimed to examine whether this bacterium could delay exercise-induced fatigue by regulating oxidative stress and altering gut microbiota. The researchers found that YF01 increased the exhaustion time of mice, as well as the levels of oxidative stress-related markers and beneficial bacteria in the gut microbiota. These findings suggest that P. pentosaceus YF01 may have potential applications in sports science and human health. [Extracted from the article]

The US Patent and Trademark Office has published a patent application titled "Microbial Consortium And Uses Thereof," which proposes new methods and microbial compositions for treating dysbiosis, infections, and inflammatory diseases. The compositions consist of different bacterial species, including Lactobacillus johnsonii, Faecalibacterium prausnitzii, Akkermansia muciniphila, Myxococcus xanthus, and Pediococcus pentosaceus. These bacteria have shown promise in modulating the immune response and altering the adaptive immune environment. The patent application provides detailed information on the specific bacterial species and their potential therapeutic applications, as well as the various forms in which the pharmaceutical composition can be administered. [Extracted from the article]

A study conducted at Federal University Vicosa in Brazil examined the antimicrobial activity of Pediococcus pentosaceus ST65ACC, a bacteriocinogenic lactic acid bacteria, against Listeria monocytogenes. The researchers evaluated the effect of different culture media on the production of bacteriocins and found that the antimicrobial activity was most effective in MRS broth, with high production of bacteriocins and consistent inhibition of L. monocytogenes. However, lower inhibitory activities were observed in BHI broth, reconstituted skim milk, and meat broth. The study suggests that the composition of the culture media may have influenced the production and activity of bacteriocins. [Extracted from the article]

A study conducted by researchers at China Agricultural University investigated the effects of different strains and wheat bran on the fermentation quality, antioxidant activity, and bacterial community of mulberry leaf silage. The study found that the groups treated with Pediococcus acidilactici, Pediococcus pentosaceus, Bacillus subtilis, and Bacillus licheniformi exhibited higher dry matter content and lower pH levels compared to the group treated with only Pediococcus acidilactici and Pediococcus pentosaceus. The group treated with all four strains showed enhanced fermentation quality and antioxidant capacity, with a favorable microbial community composition. The study suggests that the addition of wheat bran and specific bacterial strains can improve the quality of mulberry leaf silage. [Extracted from the article]

Researchers at Kurukshetra University in Haryana, India have conducted a study on the encapsulation of Pediococcus acidilactici NCDC 252, a type of Gram-Positive Bacteria, using chitosan. The aim of the study was to enhance the survivability of the bacteria in simulated gastrointestinal conditions. The researchers found that chitosan encapsulation improved the survival of NCDC 252, with a survival rate of 59.6% in gastric conditions and 68.4% in intestinal conditions. This research suggests that chitosan encapsulation could be a viable method for improving the viability of probiotics during enteric delivery. [Extracted from the article]

Researchers at Tianjin University of Science and Technology have conducted a study on Pediococcus acidilactici GQ01, a novel probiotic strain isolated from natural fermented wolfberry, and its potential effects on hyperuricemia (HUA). HUA is a disorder of purine metabolism characterized by increased uric acid production and decreased excretion. The study found that both live bacteria GQ01 and its heat-killed G1PB postbiotic were effective in reducing blood uric acid levels in a mouse model of HUA. Additionally, the probiotics and postbiotics were able to regulate the intestinal microbiota structure and improve intestinal function. The researchers suggest that P. acidilactici GQ01 and its postbiotics may have potential as functional food or drug materials for treating HUA. [Extracted from the article]

A study conducted by researchers at Zhejiang University in Hangzhou, China, has found that Pediococcus pentosaceus Li05 (Li05) may have potential benefits in relieving diarrhea-predominant irritable bowel syndrome (IBS-D). The study, which was conducted on rats, showed that Li05 effectively alleviated weight loss, visceral sensitivity, and diarrhea in rats with IBS-D. It also reduced inflammation and modulated gut microbiota and metabolism. The researchers concluded that Li05 holds promise as a potential probiotic for managing IBS-D. [Extracted from the article]

A study conducted by researchers at Democritus University of Thrace in Greece explores the potential of novel wild-type strains as probiotic candidates to manage obesity-associated insulin resistance. The study evaluates the impact of short-term dietary intervention with these strains on high-fat diet-induced insulin resistance. In vitro tests were conducted to assess the strains' survival in simulated gastrointestinal conditions, adhesion to Caco-2 cells, bile salt hydrolase secretion, cholesterol-lowering ability, and growth inhibition of food-borne pathogens. The in vivo test on insulin resistance in mice showed that supplementation with certain strains significantly improved insulin resistance compared to mice on a high-fat diet or a normal diet. [Extracted from the article]

A recent study conducted by researchers at Universitas Prima Indonesia has found that a certain strain of Pediococcus acidilactici, known as PADNH16, exhibits promising characteristics as an alpha-glucosidase inhibitor, which is commonly used to prevent and treat type 2 diabetes mellitus (T2DM). The study involved administering PADNH16 to rats with T2DM induced by streptozotocin and assessing its hypoglycemic activity and safety. The results showed that PADNH16 effectively lowered post-prandial blood glucose levels in the rats, comparable to the positive control acarbose and commercial probiotics, without causing any adverse effects on liver or kidney function, lipid profiles, or pancreatic beta cells. This research suggests that P. acidilactici strain DNH16 may have potential as a hypoglycemic agent for T2DM treatment. [Extracted from the article]

A recent study conducted by researchers at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) explored the potential anti-breast cancer effects of Pediococcus acidilactici, a probiotic bacteria isolated from human breast milk. The study found that exposure to live P. acidilactici and its cell-free supernatant (CFS) resulted in a reduction in breast cancer cell viability and increased expression of certain cytokines. Additionally, the CFS inhibited cancer cell mobility. These findings suggest that P. acidilactici may have potential as a therapeutic agent in breast cancer treatment. Further research is needed to investigate its usefulness in this regard. [Extracted from the article]

A study conducted by researchers at Kunming University in China has found that the cell-free supernatant (CFS) of Pediococcus acidilactici LWX 401, a strain of Gram-Positive Bacteria, isolated from traditional Chinese pickles, exhibits broad antibacterial activity against multidrug-resistant Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). The CFS also showed thermostability and pH tolerance, and was effective in inhibiting the formation of biofilms of these foodborne pathogens. Metabolomic analysis revealed the presence of antibacterial metabolites in the CFS, primarily lipids and organic acids. The findings of this study provide insights for the development of bio-preservatives against foodborne pathogens in the milk industry. [Extracted from the article]

A report from the University of Turin in Italy discusses the findings of a study on the microbiology and characteristics of traditional Polish fermented cucumbers. The study found that the fermented cucumbers had significant nutritional features, including high polyphenols content and antioxidant activity. Microbiological analysis revealed the presence of various bacterial populations, including lactococci, thermophilic cocci, lactobacilli, and coagulase-negative cocci. The study also identified the dominant species in the cucumbers and brine samples, such as Lactococcus, Streptococcus, Lactiplantibacillus, Leuconostoc, Pediococcus, Secundilactobacillus, and Lentilactobacillus. The research suggests that these bacteria could be used as starter or adjunct cultures for guided cucumber fermentation. The study also analyzed the volatilome of the fermented cucumbers, identifying more than 80 volatile organic compounds. The research concludes that these compounds belong to nine main classes, including oxygenated terpenes, alcohols, terpenes, ketones, acids, aldehydes, esters, sulfur, and sesquiterpenes. [Extracted from the article]

A recent report from Zhejiang University in Hangzhou, China highlights the potential benefits of a probiotic called Pediococcus pentosaceus Li05 in treating primary sclerosing cholangitis (PSC), a rare chronic liver disease. The study found that Li05 significantly reduced liver damage, inflammation, and fibrosis, as well as bile duct hyperplasia in a mouse model of cholestasis. The probiotic activated specific signaling pathways involved in bile acid synthesis and circulation, and also improved the gut microbiota and intestinal barrier. These findings suggest that Li05 may have therapeutic potential for cholestasis. [Extracted from the article]

A recent study conducted by researchers at the Zhejiang Academy of Agricultural Sciences in Hangzhou, China, explored the utilization characteristics and mechanism of action of the probiotics Bifidobacterium longum and Pediococcus pentosaceus when combined. The study used in vitro simulation technology to set up individual and mixed cultures of the two probiotics with different types of prebiotics. The results showed that the combination of B. longum and P. pentosaceus could synergistically utilize fructo oligosaccharides (FOS) and produced significantly more acetic acid than B. longum alone. These findings provide insights into the potential benefits of probiotic combinations in alleviating infantile colic symptoms by influencing gut pH and regulating gut microbiota. [Extracted from the article]

Researchers at the University of Navarra in Pamplona, Spain have conducted a study on the effects of the probiotic strain Pediococcus acidilactici (pA1c(R)) on obesity-related disturbances in rats. The study found that rats supplemented with pA1c(R) showed a decrease in visceral adiposity, an improvement in cholesterol and lipid metabolism, and a decrease in inflammation-related molecules. The study also demonstrated that pA1c(R) supplementation activated fatty acid beta-oxidation and modulated the gut microbiota. These findings suggest that pA1c(R) has potential in preventing obesity-related dyslipidemia, inflammation, and gut microbiota dysbiosis. [Extracted from the article]

A report from Handong Global University in Gyeongbuk, South Korea, discusses the production of antimicrobial peptides called bacteriocins by different strains of bacteria. The study focused on isolating and identifying specific strains of lactic acid bacteria (LAB) from fermented food products and fruits in the Pohang region of Korea. The researchers evaluated the bacteriocin production and stability of the identified strains and investigated their effects on Listeria spp. and Staphylococcus spp. The study found that the strains Pediococcus pentosaceus 732, Lactococcus lactis 808, and Lactococcus lactis subsp. lactis 431 showed promising results in terms of bacteriocin production and antimicrobial activity. [Extracted from the article]

A clinical trial, NCT06141083, is currently recruiting participants to assess the effectiveness of a probiotic supplement called TCI188 in improving oral health. The trial will measure various oral measurements, such as pocket depth and plaque index, before and after taking chewable tablets for 6-8 weeks and 12 weeks. It will also evaluate changes in inflammatory markers, oral microflora, and liver and renal function biomarkers. The study is randomized and aims to prevent periodontal diseases. The trial is being conducted in Taiwan and is expected to be completed by November 30, 2024. [Extracted from the article]

A patent has been issued to Church & Dwight Co. Inc. for compositions and methods to increase the production of isothiocyanates. Glucosinolates, found in cruciferous plants like broccoli and cabbage, have health benefits but are poorly absorbed by the body. The patent describes using specific bacterial strains to convert glucosinolates into isothiocyanates, which have chemoprotective and anti-inflammatory effects. The compositions can be administered to increase isothiocyanate production, gene expression, and treat inflammatory disorders or cancer. [Extracted from the article]

A recent study conducted by researchers at the Health Sciences Faculty has investigated the effects of probiotic orange juice containing Pediococcus acidilactici CE51 on a murine model of colitis. The study found that the probiotic treatment reduced inflammation in the small intestine, large intestine, and spleen. Additionally, the probiotic maintained the balance of gut microbiota and increased the presence of Lactobacillus helveticus. These findings suggest that the probiotic orange juice could be beneficial in modulating the gut microbiota and reducing inflammation in colitis. [Extracted from the article]

Keywords: Amylases; Enzymes and Coenzymes; Glucosidases; Gram-Positive Bacteria; Health and Medicine; Lactobacillaceae; Lactobacillales; Mutagenesis; Pediococcus EN Amylases Enzymes and Coenzymes Glucosidases Gram-Positive Bacteria Health and Medicine Lactobacillaceae Lactobacillales Mutagenesis Pediococcus 782 782 1 09/11/23 20230911 NES 230911 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Gastroenterology Week -- Current study results on pediococcus have been published. The anti-biofilm, anti-oxidant, and the inhibitory activities on a-amylase and a-glucosidase of EPS were also analyzed. [Extracted from the article]

Keywords: Bacteriocins; Gram-Positive Bacteria; Lactobacillaceae; Lactobacillales; Membrane Proteins; Pediococcus; Pore Forming Cytotoxic Proteins EN Bacteriocins Gram-Positive Bacteria Lactobacillaceae Lactobacillales Membrane Proteins Pediococcus Pore Forming Cytotoxic Proteins 1764 1764 1 07/31/23 20230731 NES 230731 2023 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Data detailed on pediococcus have been presented. Bacteriocins, Gram-Positive Bacteria, Lactobacillales, Lactobacillaceae, Membrane Proteins, Pediococcus, Pore Forming Cytotoxic Proteins. [Extracted from the article]

Jiangsu, People's Republic of China, Asia, Combinatorial, Combinatoric, Drugs and Therapies, Engineering, Genetics, Gram-Positive Bacteria, Lactobacillales, Pediococcus, Protein Expression, Proteomics, Lactobacillaceae Keywords: Jiangsu; People's Republic of China; Asia; Combinatorial; Combinatoric; Drugs and Therapies; Engineering; Genetics; Gram-Positive Bacteria; Lactobacillaceae; Lactobacillales; Pediococcus; Protein Expression; Proteomics EN Jiangsu People's Republic of China Asia Combinatorial Combinatoric Drugs and Therapies Engineering Genetics Gram-Positive Bacteria Lactobacillaceae Lactobacillales Pediococcus Protein Expression Proteomics 1243 1243 1 07/24/23 20230725 NES 230725 2023 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Gram-Positive Bacteria - Pediococcus. Based on the identified core regions of PUTRs, we constructed a panel of combinatorial PUTRs with higher and stable protein expression levels. [Extracted from the article]

According to the news reporters, the research concluded: "This suggests that the administration of milk fermented with P. acidilactici BE potentially reduces blood glucose levels and improves pancreatic beta-cell function in diabetic rats." Keywords: Yogyakarta; Indonesia; Asia; Gastroenterology; Gram-Positive Bacteria; Health and Medicine; Lactobacillaceae; Lactobacillales; Pancreas; Pediococcus; Peptide Hormones; Peptide Proteins; Proinsulin EN Yogyakarta Indonesia Asia Gastroenterology Gram-Positive Bacteria Health and Medicine Lactobacillaceae Lactobacillales Pancreas Pediococcus Peptide Hormones Peptide Proteins Proinsulin 57 57 1 07/03/23 20230703 NES 230703 2023 JUL 3 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Current study results on Gram-Positive Bacteria - Pediococcus have been published. [Extracted from the article]

Keywords: Wuhan; People's Republic of China; Asia; Enterobacteriaceae; Foodborne Diseases and Conditions; Gammaproteobacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Gram-Positive Bacteria; Hydroxy Acids; Lactates; Lactic Acid; Lactobacillaceae; Lactobacillales; Pediococcus; Proteobacteria; Salmonella EN Wuhan People's Republic of China Asia Enterobacteriaceae Foodborne Diseases and Conditions Gammaproteobacteria Gram-Negative Bacteria Gram-Negative Facultatively Anaerobic Rods Gram-Positive Bacteria Hydroxy Acids Lactates Lactic Acid Lactobacillaceae Lactobacillales Pediococcus Proteobacteria Salmonella 111 111 1 06/26/23 20230629 NES 230629 2023 JUN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Food Weekly News -- Current study results on Gram-Positive Bacteria - Pediococcus have been published. For more information on this research see: Effects of Lactic Acid Bacteria Isolated From Equine On Salmonella-infected Gut Mouse Model. [Extracted from the article]

For more information on this research see: Pediococcus Acidilactici Isolated From Traditional Cheese As a Potential Probiotic With Cytotoxic Activity Against Doxorubicin-resistant Mcf-7 Cells. Keywords: Kerman; Iran; Antibiotics; Antineoplastics; Apoptosis; Cellular Physiology; Cytotoxic Activity; Doxorubicin Therapy; Drug Resistance; Drugs and Therapies; Gram-Positive Bacteria; Health and Medicine; Lactobacillaceae; Lactobacillales; Pediococcus; Pharmaceuticals; Therapy EN Kerman Iran Antibiotics Antineoplastics Apoptosis Cellular Physiology Cytotoxic Activity Doxorubicin Therapy Drug Resistance Drugs and Therapies Gram-Positive Bacteria Health and Medicine Lactobacillaceae Lactobacillales Pediococcus Pharmaceuticals Therapy 1568 1568 1 06/19/23 20230623 NES 230623 2023 JUN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators discuss new findings in Gram-Positive Bacteria - Pediococcus. [Extracted from the article]

Keywords: Pamplona; Spain; Europe; Antidiabetic Agents; Biguanides; Drugs and Therapies; Gram-Positive Bacteria; Health and Medicine; Hypoglycemic Agents; Lactobacillaceae; Lactobacillales; Metformin; Metformin Therapy; Non-Insulin Dependent Diabetes Mellitus; Non-Sulfonylureas; Nutritional and Metabolic Diseases and Conditions; Pediococcus; Peptide Hormones; Peptide Proteins; Pharmaceuticals; Proinsulin; Type 2 Diabetes EN Pamplona Spain Europe Antidiabetic Agents Biguanides Drugs and Therapies Gram-Positive Bacteria Health and Medicine Hypoglycemic Agents Lactobacillaceae Lactobacillales Metformin Metformin Therapy Non-Insulin Dependent Diabetes Mellitus Non-Sulfonylureas Nutritional and Metabolic Diseases and Conditions Pediococcus Peptide Hormones Peptide Proteins Pharmaceuticals Proinsulin Type 2 Diabetes 169 169 1 06/19/23 20230619 NES 230619 2023 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes have been published. For more information on this research see: Pediococcus Acidilactici Pa1c((R)) Improves the Beneficial Effects of Metformin Treatment In Type 2 Diabetes By Controlling Glycaemia and Modulating Intestinal Microbiota. [Extracted from the article]

The news editors report that additional information may be obtained by contacting Warapond Wanna, Prince of Songkla University, Faculty of Sciences, Center for Genomics and Bioinformatics Research, Hat Yai 90110, Thailand. Keywords: Hat Yai; Thailand; Asia; Bacterial Infections and Mycoses; Gram-Positive Bacteria; Health and Medicine; Lactobacillaceae; Lactobacillales; Pediococcus EN Hat Yai Thailand Asia Bacterial Infections and Mycoses Gram-Positive Bacteria Health and Medicine Lactobacillaceae Lactobacillales Pediococcus 1940 1940 1 06/05/23 20230609 NES 230609 2023 JUN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in Gram-Positive Bacteria - Pediococcus. [Extracted from the article]

According to news reporting out of Cheongju, South Korea, by NewsRx editors, research stated, "Escherichia coli (E. coli) and salmonella enterica (SE) infections in pigs are major source associated with enteric disease such as post weaning diarrhea. Keywords: Cheongju; South Korea; Asia; Enterobacteriaceae; Escherichia coli; Foodborne Diseases and Conditions; Gammaproteobacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Gram-Positive Bacteria; Lactobacillaceae; Lactobacillales; Pediococcus; Proteobacteria; Salmonella; Salmonella enterica EN Cheongju South Korea Asia Enterobacteriaceae Escherichia coli Foodborne Diseases and Conditions Gammaproteobacteria Gram-Negative Bacteria Gram-Negative Facultatively Anaerobic Rods Gram-Positive Bacteria Lactobacillaceae Lactobacillales Pediococcus Proteobacteria Salmonella Salmonella enterica 22 22 1 06/05/23 20230608 NES 230608 2023 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Food Weekly News -- Investigators publish new report on Gram-Negative Bacteria - Salmonella enterica. According to the news editors, the research concluded: "Supplementation of 38W strains isolated from white kimchi can act as probiotics by inhibiting E. coli and SE.". [Extracted from the article]

Antioxidants, Drugs and Therapies, Gram-Positive Bacteria, Lactobacillaceae, Lactobacillales, Pediococcus, Protective Agents Keywords: Antioxidants; Drugs and Therapies; Gram-Positive Bacteria; Lactobacillaceae; Lactobacillales; Pediococcus; Protective Agents EN Antioxidants Drugs and Therapies Gram-Positive Bacteria Lactobacillaceae Lactobacillales Pediococcus Protective Agents 1485 1485 1 05/29/23 20230602 NES 230602 2023 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in pediococcus. [Extracted from the article]

Whole-genome sequencing showed that P. acidilactici GLP06 was 2,014,515 bp and contained 1,976 coding sequences, accounting for 86.12% of the genome, with no drug resistance genes and eight CRISPR sequences." For more information on this research see: Probiotic characteristics and whole-genome sequence analysis of Pediococcus acidilactici isolated from the feces of adult beagles. [Extracted from the article]

Keywords: Tamil Nadu; India; Asia; Apoptosis; Cancer; Cellular Physiology; Colon Cancer; DNA-Binding Proteins; Gram-Positive Bacteria; Health and Medicine; Lactobacillaceae; Lactobacillales; Oncology; PPAR gamma; Pediococcus; Peroxisome Proliferator-Activated Receptors; Proteins; Transcription Factors EN Tamil Nadu India Asia Apoptosis Cancer Cellular Physiology Colon Cancer DNA-Binding Proteins Gram-Positive Bacteria Health and Medicine Lactobacillaceae Lactobacillales Oncology PPAR gamma Pediococcus Peroxisome Proliferator-Activated Receptors Proteins Transcription Factors 702 702 1 04/17/23 20230418 NES 230418 2023 APR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Colon Cancer are discussed in a new report. Pre-treatment with PPAR gamma antagonist bisphenol A diglycidyl ether has significantly reduced the inhibitory efficacy of enhanced cell viability of HCT-116 cells, suggesting the PPAR gamma-dependent cell death. [Extracted from the article]

Keywords: Gyeongbuk; South Korea; Asia; Bacteriocins; Gram-Positive Bacteria; Lactobacillaceae; Lactobacillales; Membrane Proteins; Pediococcus; Pore Forming Cytotoxic Proteins EN Gyeongbuk South Korea Asia Bacteriocins Gram-Positive Bacteria Lactobacillaceae Lactobacillales Membrane Proteins Pediococcus Pore Forming Cytotoxic Proteins 67 67 1 04/03/23 20230406 NES 230406 2023 APR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Food Weekly News -- New research on Gram-Positive Bacteria - Pediococcus is the subject of a report. Keywords for this news article include: Asia, Gyeongbuk, South Korea, Pediococcus, Bacteriocins, Lactobacillales, Lactobacillaceae, Membrane Proteins, Gram-Positive Bacteria, Pore Forming Cytotoxic Proteins. [Extracted from the article]

"Additional aspects of the present invention refer to a Pediococcus acidilactici CECT 9889 strain, a Pediococcus acidilactici CECT 9879 strain or a Pediococcus acidilactici CECT 9967 strain as defined above for use in in the prevention and/or treatment of hyperglycemia and/or a hyperglycemia-related condition. This may be alternatively formulated as a method for regulating blood glucose levels in an animal in need thereof, including a human, comprising administering to said animal in need thereof Pediococcus acidilactici CECT 9889, Pediococcus acidilactici CECT 9879 or Pediococcus acidilactici CECT 9967. "In a still further aspect, the invention refers to a Pediococcus acidilactici CECT 9889 strain, a Pediococcus acidilactici CECT 9879 strain or a Pediococcus acidilactici CECT 9967 strain as defined above for use as a medicament. "A further aspect of the invention refers to a Pediococcus acidilactici CECT 9889 strain, a Pediococcus acidilactici CECT 9879 strain or a Pediococcus acidilactici CECT 9967 strain as defined above for use as probiotic. [Extracted from the article]

Keywords: Bacterial Polysaccharides; Bacterial Toxins; Biological Factors; Drugs and Therapies; Enterobacteriaceae; Enterotoxins; Escherichia coli; Glycoside Hydrolases; Gram-Negative Bacteria; Gram-Positive Bacteria; Lactobacillaceae; Lactobacillales; N-Glycosyl Hydrolases; Pediococcus; Prebiotics; Proteobacteria; Ribosome Inactivating Proteins; Shiga Toxins; Type 2 Ribosome Inactivating Proteins EN Bacterial Polysaccharides Bacterial Toxins Biological Factors Drugs and Therapies Enterobacteriaceae Enterotoxins Escherichia coli Glycoside Hydrolases Gram-Negative Bacteria Gram-Positive Bacteria Lactobacillaceae Lactobacillales N-Glycosyl Hydrolases Pediococcus Prebiotics Proteobacteria Ribosome Inactivating Proteins Shiga Toxins Type 2 Ribosome Inactivating Proteins 2023 FEB 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on Escherichia coli are discussed in a new report. Our data indicated that prebiotics, probiotics and their synbiotic combination could promote intestinal health through gut microbiota modulation in weaned piglets.". [Extracted from the article]